INTEGRATED BIOPHARMA INC (INBP) Net margin 2016–2025
INTEGRATED BIOPHARMA INC (INBP) net profit margin by fiscal year — reported net income divided by reported revenue.
1.5%FY2025 · since FY2016: 2.3% → 1.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1.5% | +1.3 pp |
| FY2024 | 0.2% | +0.3 pp |
| FY2023 | -0.1% | -6.9 pp |
| FY2022 | 6.8% | -5.8 pp |
| FY2021 | 12.6% | +4.8 pp |
| FY2020 | 7.8% | +4.4 pp |
| FY2019 | 3.4% | +1.8 pp |
| FY2018 | 1.6% | -3.4 pp |
| FY2017 | 5.0% | +2.7 pp |
| FY2016 | 2.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice